Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05256160 · ClinicalTrials.gov registry record · NA
Cortical Excitability in Cyclic Vomiting Syndrome
A NA study of Cyclic Vomiting Syndrome, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT05256160: Recruiting NA study of Cyclic Vomiting Syndrome, sponsored by University of Pittsburgh.
NCT05256160 is a NA study of Cyclic Vomiting Syndrome that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 110 participants, above the 96-participant average among 3 other Cyclic Vomiting Syndrome trials with a reported enrollment target (15% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05256160, a NA study of Cyclic Vomiting Syndrome, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
This exploratory study will determine if there are differences in cortical excitability between patients suffering from cyclic vomiting syndrome (CVS) and healthy control subjects, as assessed by a non-invasive method of brain stimulation (Transcranial Magnetic Stimulation, TMS).
Primary Outcome
Percentage Change in Paired Pulse (PP) TMS induced MEP responses with inhibitory or facilitatory stimulation.
Conditions Studied
Interventions
- OTHER TMS Paired-Pulse assessment of cortical excitability
- OTHER Autonomic activity
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2022-05-16 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT05256160 shows while recruiting
NCT05256160 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, above the 96-participant average among 3 other Cyclic Vomiting Syndrome trials with a reported enrollment target (15% higher).
The record links to 1 condition, with Cyclic Vomiting Syndrome appearing as the primary indexed condition, and to 2 interventions - of which TMS Paired-Pulse assessment of cortical excitability is the first listed.
NCT05256160 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05256160 about?
NCT05256160 is a clinical study titled "Cortical Excitability in Cyclic Vomiting Syndrome". This exploratory study will determine if there are differences in cortical excitability between patients suffering from cyclic vomiting syndrome (CVS) and healthy control subjects, as assessed by a non-invasive method of brain stimulation (Transcranial Magnetic Stimulation, TMS).
What is the current status of trial NCT05256160?
This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2022-05-16. Estimated completion is 2027-06.
What conditions does trial NCT05256160 study?
This clinical trial studies the following conditions: Cyclic Vomiting Syndrome.
What interventions are being tested in trial NCT05256160?
The interventions under investigation include: TMS Paired-Pulse assessment of cortical excitability (OTHER), Autonomic activity (OTHER).
Who is sponsoring clinical trial NCT05256160?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05256160 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cyclic Vomiting Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI